Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Chinese Medical Journal|August 6, 2026
Efficacy and safety of adjuvant immunotherapy after pathological complete response following neoadjuvant chemoimmunotherapy in patients with resectable NSCLC: A real-world observational studyJuan Jiang, Ziyu Zhang, Jun Zeng, et al.
Cancer Biology & Medicine|October 1, 2019
Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patientsXingsheng Hu, Dongyong Yang, Yalun Li, et al.
Eclinicalmedicine|January 23, 2024
Camrelizumab combined with apatinib and nanoparticle albumin-bound paclitaxel in lung adenocarcinoma (CAPAP-lung): a single-arm phase II studyXingxiang Pu, Gen Lin, Maoliang Xiao, et al.
Journal of Translational Medicine|November 28, 2018
Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancerXingxiang Pu, Ran Zhang, Li Wang, et al.
Heliyon|January 6, 2025
Intrathecal pemetrexed improves survival outcomes in previously treated EGFR-mutant advanced non-small-cell lung cancer with leptomeningeal metastasesLiqun Li, Zhe Huang, Yangqian Chen, et al.
Cancer Research|November 8, 2018
Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione HomeostasisXiang Yan, Xiaoshan Zhang, Li Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|March 29, 2024
Anlotinib plus docetaxel vs. docetaxel alone for advanced non-small-cell lung cancer patients who failed first-line treatment: A multicenter, randomized phase II trialXingxiang Pu, Zemin Xiao, Jia Li, et al.
Biomarker Research|January 24, 2023
The clinical and genomic distinctions of Class1/2/3 BRAF-mutant colorectal cancer and differential prognosesYungchang Chen, Hao Sun, Yanhong Deng, et al.
Future Oncology (London, England)|October 3, 2024
Efficacy in patients with EGFR-positive non-small-cell lung cancer treated with dacomitinib who had skin adverse events: post hoc analyses from ARCHER 1050Xingxiang Pu, Juan Li, Bo Zhang, et al.
The Oncologist|May 31, 2022
Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901)Wenying Peng, Liming Cao, Likun Chen, et al.
Pageof 8